Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO RegistrySalisbury AC, Karmpaliotis D, Grantham JA et al. -
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health statusQintar M, Hirai T, Salisbury AC et al.
-
Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery DiseaseKufner S, Joner M, ISAR-TEST 4 (Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents) Investigators.
-
Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI StudyZheng X, Curtis JP, China PEACE Collaborative Grou
-
Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the WeekJ Gregson, L Sharples, GW Stone et al.
-
Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching studyNakanishi R, Ceponiene I, Osawa K et al.
-
Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art ReviewG Marquis-Gravel, DJ Moliterno, SG Goodman et al.
-
A Novel Algorithm for Treating Chronic Total Coronary Artery OcclusionH Tanaka, E Tsuchikane, T Muramatsu et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
